XORTX Therapeutics Inc. (XRTX.V)

CAD 1.62

(-7.43%)

Revenue Summary of XORTX Therapeutics Inc.

  • XORTX Therapeutics Inc.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • XORTX Therapeutics Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • XORTX Therapeutics Inc. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • XORTX Therapeutics Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • XORTX Therapeutics Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • XORTX Therapeutics Inc. reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of XORTX Therapeutics Inc. (2023 - 2014)

Historical Annual Revenue of XORTX Therapeutics Inc. (2023 - 2014)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2014 - CAD 0.0%

Peer Revenue Comparison of XORTX Therapeutics Inc.

Name Revenue Revenue Difference
Arch Biopartners Inc. 1.98 Million CAD 100.0%
Covalon Technologies Ltd. 26.59 Million CAD 100.0%
Hemostemix Inc. - CAD NaN%
Universal Ibogaine Inc. 1.07 Million CAD 100.0%
Kane Biotech Inc. 148.98 Thousand CAD 100.0%
MedMira Inc. 432.52 Thousand CAD 100.0%
Marvel Biosciences Corp. - CAD NaN%
NervGen Pharma Corp. - CAD NaN%